Esr1 pvuii polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer

HIGHLIGHTS

• who: Ramadhan Karsono from the , PvuII, Breast, Hormonal, Chemotherapy, Indonesia have published the research work: ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer, in the Journal: (JOURNAL)
• what: The ESR1 gene encodes Estrogen Receptor alpha (ERα) which plays a role in the tumourigenesis of breast A single nucleotide polymorphism (SNP) in intron 1 of this gene called ESR1 PvuII (rs2234693) has been reported to increase the risk of breast This study aimed to investigate the ESR1 PvuII polymorphism as a prognostic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.